PL332821A1 - Pyrazolydinones for treating potency disorders - Google Patents

Pyrazolydinones for treating potency disorders

Info

Publication number
PL332821A1
PL332821A1 PL97332821A PL33282197A PL332821A1 PL 332821 A1 PL332821 A1 PL 332821A1 PL 97332821 A PL97332821 A PL 97332821A PL 33282197 A PL33282197 A PL 33282197A PL 332821 A1 PL332821 A1 PL 332821A1
Authority
PL
Poland
Prior art keywords
pyrazolydinones
potency disorders
treating
treating potency
disorders
Prior art date
Application number
PL97332821A
Inventor
Michael Arlt
Rochus Jonas
Pierre Schelling
Maria Christadler
Franz-Werner Kluxen
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of PL332821A1 publication Critical patent/PL332821A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
PL97332821A 1996-10-14 1997-10-08 Pyrazolydinones for treating potency disorders PL332821A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19642284A DE19642284A1 (en) 1996-10-14 1996-10-14 Pyrazolinones for the treatment of erectile dysfunction
PCT/EP1997/005532 WO1998016224A1 (en) 1996-10-14 1997-10-08 Pyrazolinones to treat disturbances of potency

Publications (1)

Publication Number Publication Date
PL332821A1 true PL332821A1 (en) 1999-10-11

Family

ID=7808669

Family Applications (1)

Application Number Title Priority Date Filing Date
PL97332821A PL332821A1 (en) 1996-10-14 1997-10-08 Pyrazolydinones for treating potency disorders

Country Status (14)

Country Link
EP (1) EP0930881A1 (en)
JP (1) JP2001501958A (en)
KR (1) KR20000049086A (en)
CN (1) CN1233178A (en)
AR (1) AR008494A1 (en)
AU (1) AU4945297A (en)
BR (1) BR9712307A (en)
CA (1) CA2268823A1 (en)
DE (1) DE19642284A1 (en)
HU (1) HUP0000233A3 (en)
NO (1) NO991734L (en)
PL (1) PL332821A1 (en)
WO (1) WO1998016224A1 (en)
ZA (1) ZA979151B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410584B1 (en) 1998-01-14 2002-06-25 Cell Pathways, Inc. Method for inhibiting neoplastic cells with indole derivatives
US6200771B1 (en) 1998-10-15 2001-03-13 Cell Pathways, Inc. Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
US6187779B1 (en) 1998-11-20 2001-02-13 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
US6369092B1 (en) 1998-11-23 2002-04-09 Cell Pathways, Inc. Method for treating neoplasia by exposure to substituted benzimidazole derivatives
US6486155B1 (en) 1998-11-24 2002-11-26 Cell Pathways Inc Method of inhibiting neoplastic cells with isoquinoline derivatives
US6034099A (en) * 1998-11-24 2000-03-07 Cell Pathways, Inc. Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
US6077842A (en) * 1998-11-24 2000-06-20 Cell Pathways, Inc. Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
US6875575B1 (en) 1998-11-25 2005-04-05 Osi Pharmaceuticals, Inc. Diagnostic methods for neoplasia
US6020379A (en) * 1999-02-19 2000-02-01 Cell Pathways, Inc. Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
DE19518082A1 (en) * 1995-05-17 1996-11-21 Merck Patent Gmbh 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one

Also Published As

Publication number Publication date
ZA979151B (en) 1998-05-11
EP0930881A1 (en) 1999-07-28
WO1998016224A1 (en) 1998-04-23
NO991734D0 (en) 1999-04-13
HUP0000233A2 (en) 2001-04-28
AR008494A1 (en) 2000-01-19
CN1233178A (en) 1999-10-27
NO991734L (en) 1999-04-13
BR9712307A (en) 1999-08-31
CA2268823A1 (en) 1998-04-23
JP2001501958A (en) 2001-02-13
AU4945297A (en) 1998-05-11
DE19642284A1 (en) 1998-04-16
HUP0000233A3 (en) 2001-06-28
KR20000049086A (en) 2000-07-25

Similar Documents

Publication Publication Date Title
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
GB9609441D0 (en) Process
AP2002002661A0 (en) Combination therapy for oesteoporosis
EP0880388A4 (en) Etherification-hydrogenation process
PL332821A1 (en) Pyrazolydinones for treating potency disorders
ZA978359B (en) Novel treatment
GB9602046D0 (en) Process
GB9615767D0 (en) Novel treatment
GB2319771B (en) Process
GB9608657D0 (en) Novel treatment
GB2316403B (en) Process
GB9625795D0 (en) Novel treatment
GB9612752D0 (en) Novel treatment
GB9606400D0 (en) Feed n treat
GB9617762D0 (en) Treatment
GB9601968D0 (en) Windshelter for sun-bathing
GB9616407D0 (en) Novel treatment
GB9616409D0 (en) Novel treatment
GB9619073D0 (en) Novel treatment
GB9616414D0 (en) Novel treatment
GB9619493D0 (en) Novel treatment
GB9625201D0 (en) Novel treatment
GB9616413D0 (en) Novel treatment
GB9616412D0 (en) Novel treatment
GB9616410D0 (en) Novel treatment